Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30174% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Sight Sciences's operating income for the twelve months ending Jun 30, 2026 was -$27.88M. For fiscal 2025 it was -$37.10M. The highest annual figure on record is -$32.19M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$37.10M | – |
| FY2024 | Dec 31, 2024 | -$50.53M | – |
| FY2023 | Dec 31, 2023 | -$57.27M | – |
| FY2022 | Dec 31, 2022 | -$83.95M | – |
| FY2021 | Dec 31, 2021 | -$51.48M | – |
| FY2020 | Dec 31, 2020 | -$32.19M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.89M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.41M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.67M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.67M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.86M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.72M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.11M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.41M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.19M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.05M | – |
| Q3 FY2022 | Sep 30, 2022 | -$21.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$22.86M | – |
| Q1 FY2022 | Mar 31, 2022 | -$22.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.72M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.66M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.43M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.36M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.69M | – |
See a number that looks wrong?